Rebecca Moss, MD Assistant Professor of Medicine, Medical Oncology Robert Wood Johnson Medical School Cancer Institute of New Jersey 195 Little Albany Street New Brunswick, NJ 08901-1914 Email: address_is_not_public_1@CINJ.org Assistant: Marisol Porter (732) 235-8663 Email: perezm5@umdnj.edu

Research Program Alignment

• Clinical Investigations Program

Membership Type: Full - Clinical

Selected Publications

Rebecca A. Moss, Clifton Lee; “Current and emerging therapies for the treatment of pancreatic cancer”; OncoTargets and Therapy, Volume 2010:3 pages 111-127, 2010.

Biren Saraiya Rashmi Chugh R, Vasiliki Karantza, Janice Mehnert, Rebecca A. Moss, Nelli Savkina, Mark N. Stein,  Lawrence H. Baker, Thomas Chenevert, Elizabeth A. Poplin.; “Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors”; Invest New Drugs, 2010 Feb;30(1):258-65. Epub 2010 Aug 10. 2010.

Janice Mehnert, Antionette Tan, Rebecca A. Moss, Elizabeth Poplin, Mark N. Stein, Mika Sovak, Kelly Levinson, Hongxia Lin, Michael Kane, Murugesan Gounder, Yong Lin, Weichung Joe Shih, Eileen White, Eric H. Rubin, , Vassiliki Karantza; “Rationally designed treatment for solid tumors with MAPK pathway activation: A Phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach”; Molecular Cancer Therapeutics, 2011. [Epub ahead of print]

Howard Burris, III, Afshin Dowlati, Rebecca A. Moss, Jeffrey Infante, Suzanne Jones, David Spigal, Kelly Levinson, Diana Lindquist, Shelby Gainer, Mohammed Dar, A Benjamin Suttle, Howard Ball, and Antoinette Tan; “Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors”; Molecular Cancer Therapeutics, 2012. Epub ahead of print]

Salma K. Jabbour, Shyamal Patel, Joseph M. Herman, Aaron Wild, Suneel N. Nagda, Taghrid Altoos, Ahmet Tunceroglu, Nilofer Azad, Susan Gearheart, Rebecca A. Moss, Elizabeth A. Poplin, Lydia L. Levinson, Ravi A. Chandra, Dirk F. Moore, Chunxia Chen, Bruce G. Hafty, and Richard Tilu; Intensity-Modulated Radiation Therapy for Rectal Carcinoma Can Reduce Treatment Breaks and Emergency Department Visits; International Journal of Surgical Oncology, Volume 2012, June 19, 2012.

Rebecca A. Moss, Dirk Moore, Mary Mulcahy, Kenneth Nahum, Biren Saraiya, Simantini Eddy, Martin Kleber, Elizabeth Poplin; A Multi-Institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer; Gastrointestinal Cancer Research, Volume 5(3):77-83, 2012.

Ahmet Tunceroglu, Joo Han Park, Sairam Balasubramanian, Matthew Poppe, Christopher Anker, Elizabeth A. Poplin, Rebecca A. Moss, N. Yue, Darren Carpizo, Christopher Gannon, Bruce G. Haffty and Salma K. Jabbour; Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer," In Press ISRN Oncology.